Edward Stewart - Merrimack Pharmaceuticals President

MACK Stock  USD 14.77  0.02  0.14%   

President

Mr. Edward J. Stewart is no longer Head of Commercial of Merrimack Pharmaceuticals Inc., with effect from March 10, 2017. Mr. Stewart served as our Senior Vice President of Business Development from March 2009 to December 2011 and in various other business development roles since he joined us in 2001. Mr. Stewart began his career at KPMG Peat Marwick LLP in the life sciences strategy consulting group since 2015.
Age 43
Tenure 9 years
Professional MarksMBA
Address One Broadway, Cambridge, MA, United States, 02142
Phone617 720 8606
Webhttps://www.merrimack.com
Stewart holds an M.B.A. from the Johnson Graduate School of Management at Cornell University and a B.S. from Bates College.

Merrimack Pharmaceuticals Management Efficiency

The company has return on total asset (ROA) of (0.0697) % which means that it has lost $0.0697 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.0622) %, meaning that it created substantial loss on money invested by shareholders. Merrimack Pharmaceuticals' management efficiency ratios could be used to measure how well Merrimack Pharmaceuticals manages its routine affairs as well as how well it operates its assets and liabilities. Return On Capital Employed is expected to rise to -0.11 this year. The value of Return On Assets is estimated to slide to -0.06. Change To Liabilities is expected to rise to about 25.5 K this year, although the value of Total Current Liabilities will most likely fall to about 418.9 K.

Similar Executives

Found 3 records

PRESIDENT Age

David UrsoMEI Pharma
52
Craig PhilipsKineta Inc
63
Eilon AsculaiMediwound
N/A
Merrimack Pharmaceuticals, Inc. operates as a biopharmaceutical company. The company was incorporated in 1993 and is headquartered in Cambridge, Massachusetts. Merrimack Pharmaceuticals operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. Merrimack Pharmaceuticals (MACK) is traded on NASDAQ Exchange in USA. It is located in One Broadway, Cambridge, MA, United States, 02142 and employs 30 people. Merrimack Pharmaceuticals is listed under Biotechnology category by Fama And French industry classification.

Management Performance

Merrimack Pharmaceuticals Leadership Team

Elected by the shareholders, the Merrimack Pharmaceuticals' board of directors comprises two types of representatives: Merrimack Pharmaceuticals inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Merrimack. The board's role is to monitor Merrimack Pharmaceuticals' management team and ensure that shareholders' interests are well served. Merrimack Pharmaceuticals' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Merrimack Pharmaceuticals' outside directors are responsible for providing unbiased perspectives on the board's policies.
George Demetri, Director
Gary Crocker, Independent Chairman of the Board
Birgit Schoeberl, Head of Discovery
Richard Peters, President CEO, Principal Financial Officer, Director
Ulrik Nielsen, Chief Scientific Officer and Sr. VP of Research
John Mendelsohn, Director
Ellen Forest, Head of Human Resources
Yasir AlWakeel, CFO and Head - Corporate Development
Daryl Drummond, Head of Research
ScD Sinskey, CoFounder Advisor
Edward Stewart, Sr. VP of Bus. Devel. and President of Merrimack Healthcare Solutions
William Sullivan, Head of Fin. and Accounting and Treasurer
Timothy Surgenor, Secretary
John Dineen, Director
Peter Laivins, Head of Devel.
Gary MBA, Treasurer and Presidentident
Geoffrey CFA, Director Communications
Robert Mulroy, CEO and President Executive Director and Member of Executive Committee
Fazal Khan, VP Manufacturing
Vivian Lee, Director
James Quigley, Director
John Green, Chief Accounting Officer, Controller
Jean Franchi, CFO,Principal Financial Officer, Principal Accounting Officer, Treasurer
William Mcclements, Head of Corporate Operations
Russell Ray, Director
Michael Porter, Independent Director
MBA MBA, Treasurer and President
Geoffrey Grande, IR Contact Officer
Sergio Santillana, Chief Medical Officer
Josh Rappaport, IR Contact Officer

Merrimack Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Merrimack Pharmaceuticals a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
When determining whether Merrimack Pharmaceuticals is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if Merrimack Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Merrimack Pharmaceuticals Stock. Highlighted below are key reports to facilitate an investment decision about Merrimack Pharmaceuticals Stock:
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Merrimack Pharmaceuticals. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in main economic indicators.
For more information on how to buy Merrimack Stock please use our How to buy in Merrimack Stock guide.
Note that the Merrimack Pharmaceuticals information on this page should be used as a complementary analysis to other Merrimack Pharmaceuticals' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the AI Investment Finder module to use AI to screen and filter profitable investment opportunities.

Complementary Tools for Merrimack Stock analysis

When running Merrimack Pharmaceuticals' price analysis, check to measure Merrimack Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Merrimack Pharmaceuticals is operating at the current time. Most of Merrimack Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Merrimack Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Merrimack Pharmaceuticals' price. Additionally, you may evaluate how the addition of Merrimack Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Commodity Directory
Find actively traded commodities issued by global exchanges
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
AI Investment Finder
Use AI to screen and filter profitable investment opportunities
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Is Merrimack Pharmaceuticals' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Merrimack Pharmaceuticals. If investors know Merrimack will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Merrimack Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.08)
Return On Assets
(0.07)
Return On Equity
(0.06)
The market value of Merrimack Pharmaceuticals is measured differently than its book value, which is the value of Merrimack that is recorded on the company's balance sheet. Investors also form their own opinion of Merrimack Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Merrimack Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Merrimack Pharmaceuticals' market value can be influenced by many factors that don't directly affect Merrimack Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Merrimack Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Merrimack Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Merrimack Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.